ZA855476B - Compounds for site-enhanced delivery of radionuclides and uses thereof - Google Patents
Compounds for site-enhanced delivery of radionuclides and uses thereofInfo
- Publication number
- ZA855476B ZA855476B ZA855476A ZA855476A ZA855476B ZA 855476 B ZA855476 B ZA 855476B ZA 855476 A ZA855476 A ZA 855476A ZA 855476 A ZA855476 A ZA 855476A ZA 855476 B ZA855476 B ZA 855476B
- Authority
- ZA
- South Africa
- Prior art keywords
- radionuclides
- site
- compounds
- enhanced delivery
- enhanced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63231484A | 1984-07-19 | 1984-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA855476B true ZA855476B (en) | 1987-03-25 |
Family
ID=24535023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA855476A ZA855476B (en) | 1984-07-19 | 1985-07-19 | Compounds for site-enhanced delivery of radionuclides and uses thereof |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0187832A1 (en) |
JP (1) | JPS61106556A (en) |
KR (1) | KR900007514B1 (en) |
AU (1) | AU4635885A (en) |
CA (1) | CA1267899A (en) |
DK (1) | DK124786A (en) |
ES (1) | ES8704900A1 (en) |
FI (1) | FI861118A0 (en) |
GR (1) | GR851792B (en) |
NO (1) | NO860981L (en) |
PT (1) | PT80841B (en) |
WO (1) | WO1986000898A1 (en) |
ZA (1) | ZA855476B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079366A (en) * | 1987-04-07 | 1992-01-07 | University Of Florida | Quarternary pyridinium salts |
US4888427A (en) * | 1987-04-07 | 1989-12-19 | University Of Florida | Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain |
EP0301751B1 (en) * | 1987-07-31 | 1993-03-10 | Takeda Chemical Industries, Ltd. | Pyridinium derivatives, their production and use |
DE4107570A1 (en) * | 1991-03-07 | 1992-11-19 | Diagnostikforschung Inst | CHELATES, THEIR METAL COMPLEXES AND THEIR USE IN DIAGNOSTICS AND THERAPY |
JP4677863B2 (en) * | 2005-09-05 | 2011-04-27 | 堺化学工業株式会社 | Thiol-based photocurable monomer and photocurable resin composition |
US8701166B2 (en) | 2011-12-09 | 2014-04-15 | Blackberry Limited | Secure authentication |
US10864279B2 (en) | 2016-12-16 | 2020-12-15 | Industrial Technology Research Institute | Linker-drug and antibody-drug conjugate (ADC) employing the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0221588A3 (en) * | 1982-05-18 | 1988-09-21 | University Of Florida | Brain-specific drug delivery |
-
1985
- 1985-07-15 AU AU46358/85A patent/AU4635885A/en not_active Abandoned
- 1985-07-15 EP EP85903633A patent/EP0187832A1/en not_active Withdrawn
- 1985-07-15 WO PCT/US1985/001334 patent/WO1986000898A1/en not_active Application Discontinuation
- 1985-07-18 GR GR851792A patent/GR851792B/el unknown
- 1985-07-18 KR KR1019850005137A patent/KR900007514B1/en not_active IP Right Cessation
- 1985-07-19 CA CA000487165A patent/CA1267899A/en not_active Expired - Lifetime
- 1985-07-19 JP JP60160040A patent/JPS61106556A/en active Pending
- 1985-07-19 PT PT80841A patent/PT80841B/en unknown
- 1985-07-19 ZA ZA855476A patent/ZA855476B/en unknown
-
1986
- 1986-02-17 ES ES552072A patent/ES8704900A1/en not_active Expired
- 1986-03-14 NO NO860981A patent/NO860981L/en unknown
- 1986-03-18 FI FI861118A patent/FI861118A0/en not_active Application Discontinuation
- 1986-03-18 DK DK124786A patent/DK124786A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK124786D0 (en) | 1986-03-18 |
JPS61106556A (en) | 1986-05-24 |
ES552072A0 (en) | 1987-04-16 |
PT80841B (en) | 1987-06-03 |
KR900007514B1 (en) | 1990-10-11 |
AU4635885A (en) | 1986-02-25 |
EP0187832A1 (en) | 1986-07-23 |
FI861118A (en) | 1986-03-18 |
ES8704900A1 (en) | 1987-04-16 |
PT80841A (en) | 1985-08-01 |
NO860981L (en) | 1986-05-20 |
FI861118A0 (en) | 1986-03-18 |
KR860000871A (en) | 1986-02-20 |
GR851792B (en) | 1985-11-26 |
WO1986000898A1 (en) | 1986-02-13 |
DK124786A (en) | 1986-05-20 |
CA1267899A (en) | 1990-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH22863A (en) | Pyrrolobenzimidazoles and pharmaceutical composition containing them | |
IL74758A (en) | Acyltripeptides and pharmaceutical compositions containing them | |
DE3565937D1 (en) | Medical composition for external application | |
GB2153678B (en) | Pharmaceutical composition | |
EP0173990A3 (en) | External pharmaceutical composition | |
NZ211145A (en) | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions | |
GB8414044D0 (en) | Administering powdered substances | |
EP0163178A3 (en) | Pharmaceutical composition | |
NZ212099A (en) | Substituted arylhydroxamates and pharmaceutical compositions | |
GB2155914B (en) | Treatment of technetium containing solns | |
PH21185A (en) | 9a-aza-9a-homoerythromycin derivatives and pharmaceutical composition containing them | |
IL74149A0 (en) | Ion chelators and pharmaceutical compositions containing them | |
GB2153677B (en) | Pharmaceutical composition | |
DE3568578D1 (en) | Beta-lactam compound and preparing thereof | |
ZA855476B (en) | Compounds for site-enhanced delivery of radionuclides and uses thereof | |
GB8523491D0 (en) | Medicinal composition | |
NZ213581A (en) | Carboxyalkyldipeptides and pharmaceutical compositions | |
PH25904A (en) | Polycyclic compounds and pharmaceutical formulations containing them | |
PH21046A (en) | Imidazole derivatives and pharmaceutical composition containing said compound | |
IL74667A (en) | Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them | |
PH23343A (en) | 8 0( acylaminoergolines and pharmaceutical compositions containing them | |
GB2161979B (en) | Radionuclides | |
DE3480340D1 (en) | Novel radioactive iodospiroperidol and process for its preparation | |
IL74168A0 (en) | 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them | |
JPS57176947A (en) | Composition and compound |